Nektar Therapeutics | NKTR - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
Agios Pharmaceuticals USD 99.65M 13.95M 2026-06
ALKERMES USD 511.53M 159.98M 2026-06
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Amgen USD 13.99B 1.95B 2026-06
Baxter International USD 2.15B 133M 2026-06
BioCryst Pharmaceuticals USD 154.97M 16.62M 2026-06
Biogen USD 1.28B 2.1B 2026-06
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Cara Therapeutics USD 19.85M 883K 2026-03
Cipla INR 10.18B 2.22B 2026-03
Dr.Reddys Laboratories INR 11.2B 4.16B 2026-06
Eisai JPY 245.42B 56.22B 2026-03
Eli Lilly USD 8.95B 3.67B 2026-06
Exelixis USD 281.45M 55.3M 2026-06
Gilead Sciences USD 7.63B 64M 2026-03
GlaxoSmithKline GBP 3.44B 292M 2026-03
Grifols EUR 979.78M 334.84M 2024-12
Halozyme Therapeutics USD 163.14M 146.61M 2026-06
Incyte USD 3.98B 33.45M 2026-06
Ionis Pharmaceuticals USD 350.06M 1.57B 2026-06
Ironwood Pharmaceuticals USD 220.47M 5.01M 2026-03
Karyopharm Therapeutics USD 90.85M 30.31M 2026-03
MacroGenics USD 113.91M 47.39M 2026-06
Merck USD 6.85B 1.52B 2026-06
Nektar Therapeutics USD 149.58M 134.46M 2026-03
Neurocrine Biosciences USD 332.4M 65.9M 2026-06
Novartis USD 7.62B 739M 2026-06
Pfizer USD 976M 727M 2026-06
Roche Holding CHF 7.55B 579M 2025-06
Sarepta Therapeutics USD 571.15M 106.7M 2026-06
Takeda JPY 460.98B 134.07B 2026-06
Teva Pharmaceutical Industries USD 3.74B 185M 2026-03
Xencor USD 44.66M 30.49M 2026-06